RESMED INC
For the period ended Mar 31, 2025. Filed Apr 24, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 24, 2025
RMD$235.74+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Information Financial Statements Condensed Consolidated Balance Sheets (Unaudited)
| PART I – FINANCIAL INFORMATION | Item 1 |
|---|
Item 1. Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
(In US$ and in thousands, except share and per share data)
| March 31,2025 | June 30,2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $932,711 | $238,361 |
| Accounts receivable, net of allowances of $19,825 and $21,132 at March 31, 2025 and June 30, 2024, respectively | 907,825 | 837,275 |
| Inventories (note 3) | 862,641 | 822,250 |
| Prepaid expenses and other current assets (note 3) | 505,243 | 459,833 |
| Total current assets | 3,208,420 | 2,357,719 |
| Non-current assets: | ||
| Property, plant and equipment, net (note 3) | 535,339 | 548,025 |
| Operating lease right-of-use assets | 152,603 | 151,121 |
| Goodwill (note 4) | 2,848,921 | 2,842,055 |
| Other intangible assets, net (note 3) | 430,109 | 485,904 |
| Deferred income taxes | 216,796 | 203,569 |
| Prepaid taxes and other non-current assets | 174,634 | 284,001 |
| Total non-current assets | 4,358,402 | 4,514,675 |
| Total assets | $7,566,822 | $6,872,394 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $222,561 | $237,728 |
| Accrued expenses | 386,325 | 377,678 |
| Operating lease liabilities, current | 28,749 | 25,278 |
| Deferred revenue | 160,445 | 152,554 |
| Income taxes payable | 132,530 | 107,517 |
| Short-term debt, net (note 7) | 9,906 | 9,900 |
| Total current liabilities | 940,516 | 910,655 |
| Non-current liabilities: | ||
| Deferred revenue | 151,090 | 137,343 |
| Deferred income taxes | 78,983 | 79,339 |
| Operating lease liabilities, non-current | 137,991 | 141,444 |
| Other long-term liabilities | 48,983 | 42,257 |
| Long-term debt, net (note 7) | 663,126 | 697,313 |
| Total non-current liabilities | 1,080,173 | 1,097,696 |
| Total liabilities | 2,020,689 | 2,008,351 |
| Commitments and contingencies (note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued | — | — |
| Common stock, $0.004 par value, 350,000,000 shares authorized; 190,125,788 issued and 146,618,775 outstanding at March 31, 2025 and 189,565,112 issued and 146,901,045 outstanding at June 30, 2024 | 761 | 588 |
| Additional paid-in capital | 1,990,137 | 1,896,604 |
| Retained earnings | 5,779,375 | 4,991,647 |
| Treasury stock, at cost, 43,507,013 shares at March 31, 2025 and 42,664,067 shares at June 30, 2024 | (1,973,284) | (1,773,267) |
| Accumulated other comprehensive loss | (250,856) | (251,529) |
| Total stockholders’ equity | 5,546,133 | 4,864,043 |
| Total liabilities and stockholders’ equity | $7,566,822 | $6,872,394 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.